| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chiroptera | 52 | 2021 | 3530 | 7.10 | Why? |
| SARS Virus | 38 | 2021 | 13021 | 2.25 | Why? |
| Genetic Variation | 16 | 2020 | 3919 | 1.73 | Why? |
| Alphacoronavirus | 5 | 2020 | 392 | 1.54 | Why? |
| Filoviridae | 3 | 2019 | 70 | 1.49 | Why? |
| Genome, Viral | 25 | 2021 | 13157 | 1.39 | Why? |
| Phylogeny | 33 | 2021 | 13341 | 1.32 | Why? |
| Disease Reservoirs | 15 | 2019 | 1672 | 1.28 | Why? |
| Camelus | 3 | 2019 | 1425 | 1.20 | Why? |
| Animals | 81 | 2021 | 78931 | 1.11 | Why? |
| Zoonoses | 12 | 2021 | 3034 | 1.09 | Why? |
| Evolution, Molecular | 11 | 2020 | 3691 | 1.06 | Why? |
| Arenaviridae | 2 | 2019 | 37 | 0.96 | Why? |
| Hepevirus | 2 | 2018 | 17 | 0.88 | Why? |
| Biological Coevolution | 1 | 2020 | 34 | 0.86 | Why? |
| Cell Lineage | 1 | 2021 | 241 | 0.84 | Why? |
| Adenoviridae | 4 | 2017 | 1151 | 0.83 | Why? |
| Molecular Sequence Data | 13 | 2017 | 3198 | 0.81 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 9 | 2020 | 8843 | 0.78 | Why? |
| Invertebrates | 1 | 2018 | 21 | 0.77 | Why? |
| Receptors, Virus | 11 | 2021 | 5659 | 0.75 | Why? |
| Severe Acute Respiratory Syndrome | 17 | 2020 | 12361 | 0.73 | Why? |
| Gene Pool | 1 | 2017 | 15 | 0.72 | Why? |
| Sequence Analysis, DNA | 12 | 2019 | 2830 | 0.72 | Why? |
| Mice, Transgenic | 5 | 2021 | 2739 | 0.72 | Why? |
| RNA Virus Infections | 2 | 2018 | 231 | 0.72 | Why? |
| Coronavirus | 15 | 2020 | 18339 | 0.70 | Why? |
| Hepadnaviridae | 1 | 2017 | 7 | 0.70 | Why? |
| Filoviridae Infections | 1 | 2017 | 13 | 0.69 | Why? |
| West Nile virus | 1 | 2019 | 206 | 0.67 | Why? |
| Viral Proteins | 7 | 2019 | 7370 | 0.66 | Why? |
| Rodentia | 1 | 2019 | 235 | 0.66 | Why? |
| Culicidae | 1 | 2019 | 239 | 0.65 | Why? |
| Viverridae | 6 | 2013 | 225 | 0.65 | Why? |
| Peptidyl-Dipeptidase A | 12 | 2020 | 9659 | 0.63 | Why? |
| DNA Virus Infections | 1 | 2017 | 88 | 0.63 | Why? |
| Virology | 2 | 2018 | 489 | 0.63 | Why? |
| Membrane Glycoproteins | 6 | 2010 | 2273 | 0.61 | Why? |
| DNA Viruses | 1 | 2017 | 184 | 0.58 | Why? |
| Spike Glycoprotein, Coronavirus | 22 | 2021 | 37182 | 0.58 | Why? |
| Societies, Scientific | 1 | 2018 | 414 | 0.57 | Why? |
| Open Reading Frames | 3 | 2019 | 1898 | 0.54 | Why? |
| Viral Envelope Proteins | 7 | 2013 | 3539 | 0.54 | Why? |
| Antibodies, Neutralizing | 16 | 2021 | 25288 | 0.53 | Why? |
| Antibodies, Viral | 22 | 2021 | 51949 | 0.50 | Why? |
| Feces | 6 | 2020 | 4235 | 0.50 | Why? |
| Communicable Diseases, Emerging | 3 | 2020 | 2523 | 0.48 | Why? |
| Insect Viruses | 1 | 2012 | 25 | 0.48 | Why? |
| RNA Viruses | 2 | 2017 | 824 | 0.48 | Why? |
| Virus Internalization | 9 | 2020 | 7921 | 0.46 | Why? |
| Coronavirus Infections | 38 | 2020 | 253789 | 0.45 | Why? |
| China | 29 | 2021 | 50654 | 0.45 | Why? |
| Coronaviridae Infections | 1 | 2015 | 442 | 0.45 | Why? |
| Amino Acid Sequence | 11 | 2020 | 6049 | 0.44 | Why? |
| Kenya | 3 | 2019 | 887 | 0.43 | Why? |
| HeLa Cells | 4 | 2020 | 1303 | 0.42 | Why? |
| Coronaviridae | 1 | 2015 | 923 | 0.38 | Why? |
| Host Specificity | 3 | 2021 | 926 | 0.38 | Why? |
| Sequence Homology | 4 | 2018 | 448 | 0.38 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2011 | 379 | 0.38 | Why? |
| Virulence Factors | 1 | 2011 | 338 | 0.37 | Why? |
| Adenoviridae Infections | 1 | 2010 | 150 | 0.37 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.36 | Why? |
| Disease Models, Animal | 4 | 2020 | 10998 | 0.36 | Why? |
| Murinae | 2 | 2018 | 25 | 0.36 | Why? |
| Cell Line | 12 | 2020 | 12040 | 0.36 | Why? |
| Meat | 2 | 2021 | 380 | 0.35 | Why? |
| Arvicolinae | 2 | 2018 | 49 | 0.35 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2021 | 11367 | 0.34 | Why? |
| Mice | 16 | 2021 | 21357 | 0.34 | Why? |
| Recombination, Genetic | 5 | 2019 | 1265 | 0.32 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3633 | 0.31 | Why? |
| Vero Cells | 11 | 2021 | 14117 | 0.31 | Why? |
| Betacoronavirus | 24 | 2020 | 204454 | 0.31 | Why? |
| Marburgvirus | 2 | 2019 | 71 | 0.30 | Why? |
| Metagenomics | 1 | 2012 | 823 | 0.30 | Why? |
| Base Sequence | 5 | 2017 | 3581 | 0.29 | Why? |
| Blood Donors | 1 | 2019 | 2956 | 0.29 | Why? |
| Virus Replication | 5 | 2020 | 14331 | 0.28 | Why? |
| Viral Structural Proteins | 2 | 2020 | 491 | 0.27 | Why? |
| Replicon | 2 | 2020 | 232 | 0.26 | Why? |
| Interferons | 2 | 2018 | 2885 | 0.26 | Why? |
| Cross Reactions | 5 | 2020 | 4374 | 0.26 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.26 | Why? |
| Viral Nonstructural Proteins | 5 | 2020 | 4810 | 0.26 | Why? |
| Polymerase Chain Reaction | 6 | 2019 | 6740 | 0.25 | Why? |
| Coronavirus, Feline | 2 | 2020 | 581 | 0.25 | Why? |
| Viral Tropism | 3 | 2020 | 1329 | 0.24 | Why? |
| Humans | 72 | 2021 | 930598 | 0.24 | Why? |
| Sequence Homology, Amino Acid | 3 | 2011 | 945 | 0.24 | Why? |
| Liver | 1 | 2017 | 4007 | 0.24 | Why? |
| Nose | 2 | 2018 | 1093 | 0.23 | Why? |
| Viral Vaccines | 5 | 2020 | 7560 | 0.23 | Why? |
| Transduction, Genetic | 2 | 2020 | 273 | 0.23 | Why? |
| Vaccines, Inactivated | 4 | 2021 | 1562 | 0.22 | Why? |
| Mice, Inbred C3H | 1 | 2020 | 102 | 0.21 | Why? |
| Encephalitis Virus, Venezuelan Equine | 1 | 2020 | 71 | 0.21 | Why? |
| Pakistan | 2 | 2019 | 2302 | 0.21 | Why? |
| Refrigeration | 1 | 2021 | 85 | 0.21 | Why? |
| Models, Molecular | 4 | 2020 | 7616 | 0.21 | Why? |
| Caspase 8 | 1 | 2020 | 92 | 0.21 | Why? |
| Swine | 3 | 2019 | 3352 | 0.21 | Why? |
| Biodiversity | 3 | 2020 | 546 | 0.20 | Why? |
| Pneumonia, Viral | 21 | 2020 | 243684 | 0.20 | Why? |
| Food Microbiology | 1 | 2021 | 114 | 0.20 | Why? |
| RNA, Viral | 14 | 2021 | 32276 | 0.20 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.20 | Why? |
| Drug Evaluation, Preclinical | 3 | 2020 | 3347 | 0.20 | Why? |
| Primates | 2 | 2021 | 584 | 0.20 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.20 | Why? |
| Tropism | 1 | 2020 | 210 | 0.20 | Why? |
| Viral Fusion Protein Inhibitors | 1 | 2020 | 88 | 0.19 | Why? |
| Farms | 1 | 2021 | 269 | 0.19 | Why? |
| Antibodies, Monoclonal | 6 | 2021 | 8041 | 0.19 | Why? |
| Virion | 2 | 2020 | 1444 | 0.19 | Why? |
| Hepatovirus | 1 | 2018 | 3 | 0.19 | Why? |
| Whole Genome Sequencing | 3 | 2018 | 3239 | 0.19 | Why? |
| Enzyme-Linked Immunosorbent Assay | 5 | 2021 | 7868 | 0.19 | Why? |
| Ebolavirus | 2 | 2019 | 834 | 0.19 | Why? |
| Animal Structures | 1 | 2018 | 61 | 0.19 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2020 | 368 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.18 | Why? |
| Phylogeography | 2 | 2020 | 824 | 0.18 | Why? |
| Selection, Genetic | 2 | 2020 | 691 | 0.18 | Why? |
| Genome Size | 1 | 2017 | 38 | 0.17 | Why? |
| Species Specificity | 4 | 2020 | 1356 | 0.17 | Why? |
| Lipopeptides | 1 | 2020 | 229 | 0.17 | Why? |
| Protein Processing, Post-Translational | 1 | 2020 | 634 | 0.17 | Why? |
| Sequence Alignment | 4 | 2020 | 2109 | 0.17 | Why? |
| Interleukin-1 | 1 | 2021 | 438 | 0.17 | Why? |
| Hantavirus | 1 | 2017 | 63 | 0.16 | Why? |
| Mink | 1 | 2021 | 399 | 0.16 | Why? |
| Base Composition | 1 | 2017 | 203 | 0.16 | Why? |
| Hepatitis, Viral, Animal | 1 | 2018 | 274 | 0.16 | Why? |
| Macrophages, Alveolar | 1 | 2020 | 668 | 0.15 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.15 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.15 | Why? |
| Nucleocapsid Proteins | 4 | 2020 | 3120 | 0.15 | Why? |
| Animal Diseases | 1 | 2018 | 182 | 0.15 | Why? |
| Membrane Fusion | 1 | 2020 | 713 | 0.15 | Why? |
| Protein Structure, Tertiary | 3 | 2020 | 1565 | 0.15 | Why? |
| Mice, Inbred C57BL | 3 | 2020 | 5542 | 0.14 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.14 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.14 | Why? |
| Disease Outbreaks | 6 | 2021 | 27595 | 0.14 | Why? |
| Terminology as Topic | 1 | 2020 | 546 | 0.14 | Why? |
| Lyssavirus | 1 | 2013 | 10 | 0.14 | Why? |
| Orthoreovirus, Mammalian | 1 | 2013 | 10 | 0.14 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.14 | Why? |
| Disease Vectors | 1 | 2015 | 208 | 0.13 | Why? |
| Glycoproteins | 1 | 2019 | 615 | 0.13 | Why? |
| Paramyxoviridae | 1 | 2013 | 67 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.13 | Why? |
| Genes, Viral | 2 | 2017 | 1428 | 0.13 | Why? |
| Cytochromes b | 2 | 2009 | 23 | 0.13 | Why? |
| Virus Shedding | 2 | 2020 | 5834 | 0.13 | Why? |
| Membrane Proteins | 2 | 2018 | 1733 | 0.13 | Why? |
| Parvoviridae | 1 | 2012 | 13 | 0.12 | Why? |
| Dicistroviridae | 1 | 2012 | 8 | 0.12 | Why? |
| Densovirinae | 1 | 2012 | 9 | 0.12 | Why? |
| Marburg Virus Disease | 1 | 2012 | 41 | 0.12 | Why? |
| Dipeptidyl Peptidase 4 | 2 | 2020 | 1061 | 0.12 | Why? |
| Nuclear Localization Signals | 1 | 2011 | 85 | 0.12 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.12 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.12 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.11 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.11 | Why? |
| HIV | 2 | 2010 | 1116 | 0.11 | Why? |
| Dogs | 1 | 2019 | 2529 | 0.11 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.11 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.11 | Why? |
| Rats | 4 | 2017 | 2764 | 0.11 | Why? |
| Cricetinae | 1 | 2019 | 3344 | 0.11 | Why? |
| Gene Products, pol | 1 | 2010 | 13 | 0.11 | Why? |
| Fluorescent Antibody Technique | 1 | 2013 | 835 | 0.11 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.10 | Why? |
| Neutralization Tests | 2 | 2017 | 6698 | 0.10 | Why? |
| Pandemics | 18 | 2021 | 389249 | 0.10 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.10 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.10 | Why? |
| Interferon-beta | 1 | 2016 | 979 | 0.10 | Why? |
| Gene Order | 1 | 2010 | 144 | 0.10 | Why? |
| Antiviral Agents | 5 | 2020 | 41703 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.10 | Why? |
| Methyltransferases | 1 | 2015 | 720 | 0.10 | Why? |
| Mutagenesis, Site-Directed | 1 | 2010 | 449 | 0.10 | Why? |
| Mutant Proteins | 1 | 2010 | 328 | 0.09 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.09 | Why? |
| Drug Discovery | 2 | 2020 | 3092 | 0.09 | Why? |
| NF-kappa B | 1 | 2016 | 1301 | 0.09 | Why? |
| Models, Genetic | 2 | 2009 | 434 | 0.09 | Why? |
| Mice, Inbred BALB C | 3 | 2020 | 5814 | 0.09 | Why? |
| Female | 14 | 2021 | 380317 | 0.09 | Why? |
| Protein Interaction Domains and Motifs | 3 | 2020 | 2134 | 0.09 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.09 | Why? |
| Virus Attachment | 1 | 2015 | 1259 | 0.09 | Why? |
| Chimera | 1 | 2007 | 83 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.08 | Why? |
| Molecular Epidemiology | 1 | 2013 | 1638 | 0.08 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.08 | Why? |
| Green Fluorescent Proteins | 1 | 2008 | 450 | 0.08 | Why? |
| Gene Deletion | 1 | 2008 | 430 | 0.08 | Why? |
| Immune Evasion | 2 | 2020 | 2081 | 0.08 | Why? |
| Murine hepatitis virus | 1 | 2015 | 1720 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Hemagglutinins, Viral | 1 | 2006 | 176 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.07 | Why? |
| Research | 1 | 2018 | 2115 | 0.07 | Why? |
| Antigens, Viral | 3 | 2020 | 6298 | 0.07 | Why? |
| Protein Interaction Mapping | 1 | 2007 | 487 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2020 | 4624 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Prevalence | 3 | 2018 | 25773 | 0.07 | Why? |
| Interleukin-8 | 2 | 2021 | 964 | 0.07 | Why? |
| Virus Assembly | 1 | 2007 | 438 | 0.07 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.07 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.07 | Why? |
| Interleukin-1beta | 2 | 2020 | 992 | 0.07 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.07 | Why? |
| Cloning, Molecular | 1 | 2007 | 1036 | 0.07 | Why? |
| Virulence | 1 | 2011 | 2172 | 0.07 | Why? |
| Europe | 1 | 2021 | 12702 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.07 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.06 | Why? |
| Amino Acid Substitution | 1 | 2010 | 1706 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Leukocytes, Mononuclear | 2 | 2010 | 2115 | 0.06 | Why? |
| Peptides | 1 | 2015 | 2513 | 0.06 | Why? |
| Immunodominant Epitopes | 1 | 2007 | 813 | 0.06 | Why? |
| Sputum | 2 | 2021 | 1720 | 0.06 | Why? |
| Genetic Vectors | 1 | 2010 | 1600 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2018 | 13720 | 0.06 | Why? |
| Interferon-gamma | 2 | 2010 | 2711 | 0.06 | Why? |
| Carrier State | 2 | 2020 | 2100 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Recombinant Proteins | 2 | 2010 | 3786 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Rabbits | 2 | 2020 | 1171 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2016 | 11041 | 0.06 | Why? |
| HEK293 Cells | 3 | 2020 | 8394 | 0.06 | Why? |
| Food Handling | 1 | 2021 | 103 | 0.05 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2012 | 1475 | 0.05 | Why? |
| Cell Line, Transformed | 1 | 2020 | 87 | 0.05 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.05 | Why? |
| Sincalide | 1 | 2020 | 10 | 0.05 | Why? |
| Propiolactone | 1 | 2020 | 83 | 0.05 | Why? |
| Aluminum Hydroxide | 1 | 2020 | 133 | 0.05 | Why? |
| Proprotein Convertases | 1 | 2020 | 28 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Longitudinal Studies | 1 | 2016 | 9893 | 0.05 | Why? |
| Chemokine CCL5 | 1 | 2020 | 169 | 0.05 | Why? |
| Hyperplasia | 1 | 2020 | 204 | 0.05 | Why? |
| Interleukin-7 | 1 | 2020 | 148 | 0.05 | Why? |
| Dendritic Cells | 1 | 2008 | 1330 | 0.05 | Why? |
| Trypsin | 1 | 2020 | 209 | 0.05 | Why? |
| Receptors, Fc | 1 | 2020 | 153 | 0.05 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2020 | 593 | 0.05 | Why? |
| Phosphoproteins | 2 | 2020 | 4346 | 0.05 | Why? |
| Child | 2 | 2018 | 70012 | 0.05 | Why? |
| Cytosol | 1 | 2018 | 77 | 0.05 | Why? |
| Cell Fusion | 1 | 2020 | 400 | 0.05 | Why? |
| Jejunum | 1 | 2018 | 82 | 0.04 | Why? |
| Viral Matrix Proteins | 1 | 2006 | 1243 | 0.04 | Why? |
| Shrews | 1 | 2017 | 28 | 0.04 | Why? |
| Amino Acid Motifs | 1 | 2020 | 620 | 0.04 | Why? |
| Toll-Like Receptor 9 | 1 | 2018 | 72 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2020 | 800 | 0.04 | Why? |
| Sendai virus | 1 | 2018 | 111 | 0.04 | Why? |
| Virus Cultivation | 1 | 2021 | 579 | 0.04 | Why? |
| Macau | 1 | 2017 | 116 | 0.04 | Why? |
| Conserved Sequence | 1 | 2020 | 751 | 0.04 | Why? |
| Sensitivity and Specificity | 2 | 2016 | 22971 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Biological Assay | 1 | 2020 | 367 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Computational Biology | 1 | 2012 | 4514 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.04 | Why? |
| Protein Domains | 2 | 2020 | 6563 | 0.04 | Why? |
| Receptors, IgG | 1 | 2020 | 578 | 0.04 | Why? |
| Cattle | 1 | 2020 | 1336 | 0.04 | Why? |
| Geography, Medical | 1 | 2019 | 537 | 0.04 | Why? |
| Protein Structure, Secondary | 1 | 2020 | 1077 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Bayes Theorem | 2 | 2020 | 3237 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2020 | 1132 | 0.04 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.04 | Why? |
| Sequence Analysis, RNA | 2 | 2018 | 2290 | 0.04 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Cats | 1 | 2020 | 1890 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.03 | Why? |
| Luciferases | 1 | 2015 | 378 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2020 | 2219 | 0.03 | Why? |
| Hepatitis E | 1 | 2017 | 319 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2020 | 2275 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2015 | 9044 | 0.03 | Why? |
| Viral Core Proteins | 1 | 2012 | 134 | 0.03 | Why? |
| RNA | 1 | 2020 | 1278 | 0.03 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2020 | 1269 | 0.03 | Why? |
| Ribonucleoproteins | 1 | 2012 | 151 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.03 | Why? |
| Interleukin-6 | 1 | 2010 | 7522 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.03 | Why? |
| Nucleoproteins | 1 | 2012 | 223 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.03 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.02 | Why? |
| Singapore | 1 | 2019 | 3641 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Alanine Transaminase | 1 | 2015 | 1329 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Baculoviridae | 1 | 2008 | 132 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Drug Design | 1 | 2020 | 2627 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.02 | Why? |
| Interleukin-4 | 1 | 2008 | 367 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Henipavirus | 1 | 2005 | 24 | 0.02 | Why? |
| Horses | 1 | 2007 | 474 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Receptors, Cell Surface | 1 | 2010 | 586 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Plasmids | 1 | 2008 | 840 | 0.02 | Why? |
| Aged | 2 | 2020 | 215776 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.02 | Why? |
| Th1 Cells | 1 | 2008 | 1228 | 0.01 | Why? |
| Cell Differentiation | 1 | 2008 | 1338 | 0.01 | Why? |
| Immune System | 1 | 2008 | 1479 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Phenotype | 1 | 2008 | 4037 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.01 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4545 | 0.01 | Why? |
| Population Surveillance | 1 | 2007 | 4967 | 0.01 | Why? |